TY - JOUR T1 - Glucocorticoid withdrawal in lupus – to do or not to do? JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - e44 LP - e44 DO - 10.1136/annrheumdis-2020-217261 VL - 81 IS - 3 AU - Nupoor Acharya Y1 - 2022/03/01 UR - http://ard.bmj.com/content/81/3/e44.abstract N2 - I read with great interest, the recently published article in your journal titled “Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial” by Mathian et al.1 The discussion on the feasibility of completely stopping glucocorticoids in systemic lupus erythematosus (SLE) has been ongoing and it poses a practical challenge to every physician treating SLE. Besides the adverse effects, studies also suggest that long term glucocorticoid therapy for remission maintenance in SLE leads to increased accrual of organ damage.2 The effect of withdrawal of glucocorticoids on … ER -